{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:45:04Z","timestamp":1792158304164,"version":"4.4.0"},"reference-count":66,"publisher":"Europa Digital & Publishing","issue":"R","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.4244\/eijv9sra22","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T14:37:26Z","timestamp":1412260646000},"page":"R127-R135","source":"Crossref","is-referenced-by-count":36,"title":["Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation"],"prefix":"10.4244","volume":"9","author":[{"given":"Dagmara","family":"Hering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray D.","family":"Esler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-2014730135637-0","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1053\/ajkd.2001.27392","article-title":"Cardiovascular disease in end-stage renal disease patients.","volume":"38","author":"Collins AJ.","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"key-2014730135637-1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(88)92357-4","article-title":"Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients.","volume":"2","author":"Gruppo Emodialisi e Patologie Cardiovasculari.","year":"1988","journal-title":"Lancet."},{"key":"key-2014730135637-2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.","volume":"351","author":"Anavekar NS.","year":"2004","journal-title":"N Engl J Med."},{"key":"key-2014730135637-3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.7326\/0003-4819-144-3-200602070-00005","article-title":"Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.","volume":"144","author":"Rahman M.","year":"2006","journal-title":"Ann Intern Med."},{"key":"key-2014730135637-4","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1046\/j.1523-1755.63.s84.17.x","article-title":"Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome.","author":"Herzog CA.","year":"2003","journal-title":"Kidney Int Suppl."},{"key":"key-2014730135637-5","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1681\/ASN.2005010112","article-title":"Projecting the number of patients with end-stage renal disease in the United States to the year 2015.","volume":"16","author":"Gilbertson DT.","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"key-2014730135637-6","article-title":"http:\/\/kidney.niddk.nih.gov\/kudiseases\/pubs\/kustats\/. [Downloaded on 27 January 2013]."},{"key":"key-2014730135637-7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data.","volume":"365","author":"Kearney PM.","year":"2005","journal-title":"Lancet."},{"key":"key-2014730135637-8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.","volume":"21","author":"King H.","year":"1998","journal-title":"Diabetes Care."},{"key":"key-2014730135637-9","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"117","author":"Calhoun DA.","year":"2008","journal-title":"Circulation."},{"key":"key-2014730135637-10","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients.","volume":"125","author":"Daugherty SL.","year":"2012","journal-title":"Circulation."},{"key":"key-2014730135637-11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/01.ASN.0000113320.57127.B9","article-title":"Sympathetic hyperactivity in chronic renal failure: A wake-up call.","volume":"15","author":"Koomans HA.","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"key-2014730135637-12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1093\/ndt\/15.11.1735","article-title":"Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?","volume":"15","author":"Rump LC.","year":"2000","journal-title":"Nephrol Dial Transplant."},{"key":"key-2014730135637-13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11906-002-0016-3","article-title":"Neurogenic factors in renal hypertension.","volume":"4","author":"Campese VM.","year":"2002","journal-title":"Curr Hypertens Rep."},{"key":"key-2014730135637-14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11906-002-0012-7","article-title":"Sympathetic nervous system function in renal hypertension.","volume":"4","author":"Tuncel M.","year":"2002","journal-title":"Curr Hypertens Rep."},{"key":"key-2014730135637-15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1681\/ASN.2008040402","article-title":"Sympathetic activation in chronic renal failure.","volume":"20","author":"Schlaich MP.","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"key-2014730135637-16","first-page":"281","article-title":"Plasma noradrenaline levels in regular haemodialysis patients.","volume":"12","author":"Brecht HM.","year":"1976","journal-title":"Proc Eur Dial Transplant Assoc."},{"key":"key-2014730135637-17","first-page":"89","article-title":"Catecholamines in peripheral venous plasma in patients on chronic haemodialysis.","volume":"55","author":"McGrath BP.","year":"1978","journal-title":"Clin Sci Mol Med."},{"key":"key-2014730135637-18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ndt\/16.suppl_1.67","article-title":"Sympathetic overactivity and arterial hypertension in renal failure.","volume":"16 Suppl 1","author":"Orth SR.","year":"2001","journal-title":"Nephrol Dial Transplant."},{"key":"key-2014730135637-19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ki.1977.114","article-title":"Autonomic blockade and the valsalva maneuver in patients on maintenance hemodialysis: a hemodynamic study.","volume":"12","author":"McGrath BP.","year":"1977","journal-title":"Kidney Int."},{"key":"key-2014730135637-20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000183111","article-title":"Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine.","volume":"36","author":"Levitan D.","year":"1984","journal-title":"Nephron."},{"key":"key-2014730135637-21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/ki.1985.203","article-title":"Norepinephrine-related mechanism in hypertension accompanying renal failure.","volume":"28","author":"Schohn D.","year":"1985","journal-title":"Kidney Int."},{"key":"key-2014730135637-22","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure.","volume":"327","author":"Converse RL Jr.","year":"1992","journal-title":"N Engl J Med."},{"key":"key-2014730135637-23","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease.","volume":"106","author":"Hausberg M.","year":"2002","journal-title":"Circulation."},{"key":"key-2014730135637-24","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","article-title":"Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.","volume":"340","author":"Ligtenberg G.","year":"1999","journal-title":"N Engl J Med."},{"key":"key-2014730135637-25","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","article-title":"Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension.","volume":"12","author":"Klein IH.","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"key-2014730135637-26","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.110.164780","article-title":"Early sympathetic activation in the initial clinical stages of chronic renal failure.","volume":"57","author":"Grassi G.","year":"2011","journal-title":"Hypertension."},{"key":"key-2014730135637-27","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.","volume":"105","author":"Zoccali C.","year":"2002","journal-title":"Circulation."},{"key":"key-2014730135637-28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/ndt\/gfg059","article-title":"Why is coronary heart disease of uraemic patients so frequent and so devastating?","volume":"18","author":"Amann K.","year":"2003","journal-title":"Nephrol Dial Transplant."},{"key":"key-2014730135637-29","first-page":"E763","article-title":"Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure.","volume":"262","author":"Reid IA.","year":"1992","journal-title":"Am J Physiol."},{"key":"key-2014730135637-30","first-page":"R690","article-title":"Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans.","volume":"261","author":"Matsukawa T.","year":"1991","journal-title":"Am J Physiol."},{"key":"key-2014730135637-31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ajkd.2002.29865","article-title":"Leptin and renal disease.","volume":"39","author":"Wolf G.","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"key-2014730135637-32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.ASN.0000106717.58091.F6","article-title":"Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease.","volume":"15","author":"Mallamaci F.","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"key-2014730135637-33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/HJH.0b013e3280102d92","article-title":"Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure.","volume":"25","author":"Hering D.","year":"2007","journal-title":"J Hypertens."},{"key":"key-2014730135637-34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/01.HYP.0000121881.77212.b1","article-title":"Causes and consequences of increased sympathetic activity in renal disease.","volume":"43","author":"Joles JA.","year":"2004","journal-title":"Hypertension."},{"key":"key-2014730135637-35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/01.HYP.0000113047.47711.fa","article-title":"The sympathetic nervous system and hypertension: recent developments.","volume":"43","author":"DiBona GF.","year":"2004","journal-title":"Hypertension."},{"key":"key-2014730135637-36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0272-6386(95)90456-5","article-title":"Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.","volume":"26","author":"Campese VM.","year":"1995","journal-title":"Am J Kidney Dis."},{"key":"key-2014730135637-37","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.HYP.25.4.878","article-title":"Renal afferent denervation prevents hypertension in rats with chronic renal failure.","volume":"25","author":"Campese VM.","year":"1995","journal-title":"Hypertension."},{"key":"key-2014730135637-38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/01.HYP.0000047205.52509.8A","article-title":"Neural control of the kidney: past, present, and future.","volume":"41","author":"DiBona GF.","year":"2003","journal-title":"Hypertension."},{"key":"key-2014730135637-39","doi-asserted-by":"publisher","first-page":"I155","DOI":"10.1161\/01.HYP.5.2_Pt_2.I155","article-title":"Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats.","volume":"5","author":"Faber JE.","year":"1983","journal-title":"Hypertension."},{"key":"key-2014730135637-40","doi-asserted-by":"crossref","first-page":"337 (April).","DOI":"10.1016\/S0022-5347(17)73688-9","article-title":"Resection of the nerves of the kidney for nephralgia and small hydronephrosis.","volume":"11","author":"Papin E.","year":"1924","journal-title":"J Urol."},{"key":"key-2014730135637-41","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0895-7061(98)00154-X","article-title":"Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients.","volume":"11","author":"Zazgornik J.","year":"1998","journal-title":"Am J Hypertens."},{"key":"key-2014730135637-42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function.","volume":"77","author":"DiBona GF.","year":"1997","journal-title":"Physiol Rev."},{"key":"key-2014730135637-43","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.","volume":"373","author":"Krum H.","year":"2009","journal-title":"Lancet."},{"key":"key-2014730135637-44","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial.","volume":"376","author":"Esler MD.","year":"2010","journal-title":"Lancet."},{"key":"key-2014730135637-45","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.","volume":"57","author":"Symplicity HTN-1 Investigators.","year":"2011","journal-title":"Hypertension."},{"key":"key-2014730135637-46","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.","volume":"126","author":"Esler MD.","year":"2012","journal-title":"Circulation."},{"key":"key-2014730135637-47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.","volume":"60","author":"Mahfoud F.","year":"2012","journal-title":"Hypertension."},{"key":"key-2014730135637-48","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1681\/ASN.2011111062","article-title":"Renal denervation in moderate to severe CKD.","volume":"23","author":"Hering D.","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"key-2014730135637-49","article-title":"Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.","volume":"Epub AOP","author":"Schlaich MP.","year":"2013","journal-title":"Int J Cardiol."},{"key":"key-2014730135637-50","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.ijcard.2011.11.054","article-title":"Renal nerve ablation reduces blood pressure in a patient with renovascular hypertension resistant to drug and revascularisation therapies.","volume":"159","author":"Hering D.","year":"2012","journal-title":"Int J Cardiol."},{"key":"key-2014730135637-51","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1093\/ndt\/gfs044","article-title":"Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient.","volume":"27","author":"Di Daniele N.","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"key-2014730135637-52","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/j.ijcard.2012.05.114","article-title":"Percutaneous transluminal renal denervation: a potential treatment option for polycystic kidney disease-related pain?","volume":"162","author":"Shetty SV.","year":"2013","journal-title":"Int J Cardiol."},{"key":"key-2014730135637-53","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.","volume":"375","author":"Rothwell PM.","year":"2010","journal-title":"Lancet."},{"key":"key-2014730135637-54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.HYP.38.3.434","article-title":"Arterial wave reflections and survival in end-stage renal failure.","volume":"38","author":"London GM.","year":"2001","journal-title":"Hypertension."},{"key":"key-2014730135637-55","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease.","volume":"20","author":"McClellan W.","year":"2004","journal-title":"Curr Med Res Opin."},{"key":"key-2014730135637-56","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1523-1755.2004.00425.x","article-title":"Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients.","volume":"65","author":"Li S.","year":"2004","journal-title":"Kidney Int."},{"key":"key-2014730135637-57","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1046\/j.1523-1755.2003.00109.x","article-title":"Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.","volume":"64","author":"Abramson JL.","year":"2003","journal-title":"Kidney Int."},{"key":"key-2014730135637-58","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/HJH.0b013e328344db3a","article-title":"Renal denervation: a potential new treatment modality for polycystic ovary syndrome?","volume":"29","author":"Schlaich MP.","year":"2011","journal-title":"J Hypertens."},{"key":"key-2014730135637-59","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.111.173799","article-title":"Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.","volume":"58","author":"Witkowski A.","year":"2011","journal-title":"Hypertension."},{"key":"key-2014730135637-60","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.","volume":"123","author":"Mahfoud F.","year":"2011","journal-title":"Circulation."},{"key":"key-2014730135637-61","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM199307293290508","article-title":"Autosomal dominant polycystic kidney disease.","volume":"329","author":"Gabow PA.","year":"1993","journal-title":"N Engl J Med."},{"key":"key-2014730135637-62","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/S0022-5347(06)00336-3","article-title":"Laparoscopic renal denervation and nephropexy for autosomal dominant polycystic kidney disease related pain in adolescents.","volume":"175","author":"Resnick M.","year":"2006","journal-title":"J Urol."},{"key":"key-2014730135637-63","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"25","author":"Mancia G.","year":"2007","journal-title":"J Hypertens."},{"key":"key-2014730135637-64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00041552-200203000-00011","article-title":"Sympathetic nervous system and the kidney in hypertension.","volume":"11","author":"DiBona GF.","year":"2002","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"key-2014730135637-65","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1161\/01.CIR.99.19.2537","article-title":"Increased sympathetic nerve activity in renovascular hypertension.","volume":"99","author":"Johansson M.","year":"1999","journal-title":"Circulation."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T19:02:36Z","timestamp":1650308556000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/R_issue\/22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":66,"journal-issue":{"issue":"R","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["EIJV9SRA22"],"URL":"https:\/\/doi.org\/10.4244\/eijv9sra22","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}